{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T18:02:03Z","timestamp":1780164123567,"version":"3.54.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Bandirma Onyedi Eylul University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Obesity and its associated type 2 diabetes mellitus (T2DM) represent a growing public health challenge worldwide. This study aimed to evaluate the cost-effectiveness of sleeve gastrectomy (SG) compared with pharmacological therapy (PT) in patients with obesity and T2DM from the perspective of the reimbursement institution in T\u00fcrkiye.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A Markov cohort model was developed to evaluate the cost-effectiveness of SG compared with PT in patients with obesity and T2DM. The model simulated a cohort of 1,000 individuals entering the model at age 40 years over a 60-year lifetime horizon from the perspectives of the Social Security Institution (SGK) and the Public Health Service Price Schedule (PHSP). Cost data were obtained from hospital records of 44 patients receiving PT and 55 patients undergoing SG, while effectiveness inputs were derived from published literature. Costs were calculated for the 2023 price year, and both costs and health outcomes were discounted at an annual rate of 3%. One-way and probabilistic sensitivity analyses were performed to assess parameter uncertainty.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>According to the Markov model results, lifetime total costs were estimated at US$3,412.9 for PT and US$4,043.8 for SG. Lifetime health outcomes, measured in quality-adjusted life years (QALYs), were 11.33 for PT and 12.68 for SG. Compared with PT, SG provided an additional 1.35 QALYs at an incremental cost of US$630.9, corresponding to an incremental cost-effectiveness ratio (ICER) of US$467 per QALY gained.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The results indicate that SG is a cost-effective treatment option for patients with obesity and T2DM in T\u00fcrkiye, providing greater health benefits at an acceptable incremental cost compared with PT. The relatively lower healthcare costs in T\u00fcrkiye may further enhance the long-term cost-effectiveness of SG.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11695-026-08639-9","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:57:35Z","timestamp":1775066255000},"page":"2013-2024","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost-Effectiveness Analysis of Bariatric Surgery and Pharmacological Treatments for People with Obesity and Type 2 Diabetes Mellitus"],"prefix":"10.1007","volume":"36","author":[{"given":"Dolunay \u00d6zlem","family":"Zeybek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahit","family":"Yi\u011fit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"8639_CR1","first-page":"142","volume":"38","author":"AS Barnes","year":"2011","unstructured":"Barnes AS, Coulter SA. The Epidemic of Obesity and Diabetes: Trends and Treatments. Tex Heart Inst J. 2011;38:142.","journal-title":"Tex Heart Inst J"},{"key":"8639_CR2","doi-asserted-by":"publisher","unstructured":"Nianogo RA, Arah OA. Forecasting obesity and type 2 diabetes incidence and burden: The vila-obesity simulation model. Front Public Health. 2022;10:1\u201313.\u00a0https:\/\/doi.org\/10.3389\/fpubh.2022.818816","DOI":"10.3389\/fpubh.2022.818816"},{"key":"8639_CR3","doi-asserted-by":"publisher","unstructured":"WHO & IDF. Diagnosis and Management of Type 2 Diabetes. (2020) https:\/\/doi.org\/10.1016\/S0212-6567(10)70002-0","DOI":"10.1016\/S0212-6567(10)70002-0"},{"key":"8639_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2013.10.013","author":"International Diabetes Federation","year":"2021","unstructured":"International Diabetes Federation. IDF Diabetes Atlas. Int Diabetes Federation. 2021. https:\/\/doi.org\/10.1016\/j.diabres.2013.10.013.","journal-title":"Int Diabetes Federation"},{"key":"8639_CR5","first-page":"223","volume":"8","author":"A Yi\u011fit","year":"2019","unstructured":"Yi\u011fit A, Yi\u011fit V. Economic Burden of Obesity-Related Comorbidities in T\u00fcrkiye. G\u00fcm\u00fc\u015fhane \u00dcniversitesi Sa\u011fl\u0131k Bilimleri Dergisi Ara\u015ft\u0131rma Makalesi GUJHS. 2019;8:223\u201330.","journal-title":"G\u00fcm\u00fc\u015fhane \u00dcniversitesi Sa\u011fl\u0131k Bilimleri Dergisi Ara\u015ft\u0131rma Makalesi GUJHS"},{"key":"8639_CR6","first-page":"24","volume":"3","author":"EE \u00d6cal","year":"2018","unstructured":"\u00d6cal EE, \u00d6ns\u00fcz MF. Diyabet Hastal\u0131\u011f\u0131n\u0131n Ekonomik Y\u00fck\u00fc. T\u00fcrk D\u00fcnyas\u0131 Uygulama ve Ara\u015ft\u0131rma Merkezi Halk Sa\u011fl\u0131\u011f\u0131 Dergisi. 2018;3:24\u201331.","journal-title":"T\u00fcrk D\u00fcnyas\u0131 Uygulama ve Ara\u015ft\u0131rma Merkezi Halk Sa\u011fl\u0131\u011f\u0131 Dergisi"},{"key":"8639_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3111\/13696990701605235","volume":"10","author":"D Chisholm","year":"2007","unstructured":"Chisholm D, Evans DB. Economic Evaluation in Health: Saving Money or \u0130mproving Care. J Med Econ. 2007;10:325\u201337.","journal-title":"J Med Econ"},{"key":"8639_CR8","first-page":"1","volume":"2","author":"A Botchkarev","year":"2016","unstructured":"Botchkarev A. Essential Notion of the Health Economic Evaluation: Definition. Atl Rev Econ. 2016;2:1\u201315.","journal-title":"Atl Rev Econ"},{"key":"8639_CR9","first-page":"822","volume":"60","author":"M Drummond","year":"2006","unstructured":"Drummond M. Methods for the Economic Evaluation of Health Care Programmes. J Epidemiol Community Health (1978). 2006;60:822. 3rd ed.","journal-title":"J Epidemiol Community Health (1978)"},{"key":"8639_CR10","unstructured":"TEMD. Obezite Tan\u0131 ve Tedavi K\u0131lavuzu. T\u00fcrkiye Endokrinoloji ve Metabolizma Derne\u011fi. 2017."},{"key":"8639_CR11","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1007\/s11695-018-3593-1","volume":"29","author":"R Welbourn","year":"2019","unstructured":"Welbourn R, et al. Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Fourth IFSO Global Registry Report 2018. Obes Surg. 2019;29:782\u201395.","journal-title":"Obes Surg"},{"key":"8639_CR12","unstructured":"\u00d6zatkan Y. Obezite Cerrahisinin Ya\u015fam Kalitesine Etkisi ve Maliyet: Hasta Perspektifinden Bir De\u011ferlendirme. Ankara \u00dcniversitesi; 2021."},{"key":"8639_CR13","doi-asserted-by":"crossref","unstructured":"Jordan K, Fawsitt CG, Carty PG, Clyne B, Teljeur C, Harrington P, Ryan M. Cost-effectiveness of metabolic surgery for the treatment of type 2 diabetes and obesity: a systematic review of economic evaluations. Eur J Health Econ. 2023;24(4):575\u2013590.","DOI":"10.1007\/s10198-022-01494-2"},{"key":"8639_CR14","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.18506\/anemon.1355355","volume":"11","author":"D\u00d6 Zeybek","year":"2023","unstructured":"Zeybek D\u00d6, Yi\u011fit V. Cost Effectiveness of Bariatric Surgical Treatment Methods: A Systematic Review. Anemon Mu\u015f Alparslan \u00dcniversitesi Sosyal Bilimler Dergisi. 2023;11:1001\u201317.","journal-title":"Anemon Mu\u015f Alparslan \u00dcniversitesi Sosyal Bilimler Dergisi"},{"key":"8639_CR15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2337\/dc08-1749","volume":"32","author":"CL Keating","year":"2009","unstructured":"Keating CL, et al. Cost-Effectiveness of Surgically Induced Weight Loss for the Management of Type 2 Diabetes: Modeled Lifetime Analysis. Diabetes Care. 2009;32:567.","journal-title":"Diabetes Care"},{"key":"8639_CR16","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1177\/1559827620930962","volume":"14","author":"J Kelly","year":"2020","unstructured":"Kelly J, Karlsen M, Steinke G. Type 2 Diabetes Remission and Lifestyle Medicine: A Position Statement From the American College of Lifestyle Medicine. Am J Lifestyle Med. 2020;14:406\u201319.","journal-title":"Am J Lifestyle Med"},{"key":"8639_CR17","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.2337\/dc09-9036","volume":"32","author":"JB Buse","year":"2009","unstructured":"Buse JB, et al. How Do We Define Cure of Diabetes? Diabetes Care. 2009;32:2133.","journal-title":"Diabetes Care"},{"key":"8639_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/0272989X221121747","volume":"43","author":"F Alarid-Escudero","year":"2023","unstructured":"Alarid-Escudero F, et al. A Tutorial on Time-Dependent Cohort State-Transition Models in R using a Cost-Effectiveness Analysis Example. Med Decis Mak. 2023;43:21.","journal-title":"Med Decis Mak"},{"key":"8639_CR19","unstructured":"T\u00dc\u0130K. \u00d6l\u00fcm ve \u00d6l\u00fcm Nedeni \u0130statistikleri. 2022. https:\/\/data.tuik.gov.tr\/Bulten\/Index?p=Olum-ve-Olum-Nedeni-Istatistikleri-2022-49679 (2023)."},{"key":"8639_CR20","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1381\/096089206778870067","volume":"16","author":"R Ackroyd","year":"2006","unstructured":"Ackroyd R, Mouiel J, Chevallier JM, Daoud F. Cost-Effectiveness and Budget \u0130mpact of Obesity Surgery in Patients With Type-2 Diabetes in Three European Countries. Obes Surg. 2006;16:1488\u2013503.","journal-title":"Obes Surg"},{"key":"8639_CR21","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1007\/s11695-009-9946-z","volume":"19","author":"M Anselmino","year":"2009","unstructured":"Anselmino M, et al. Cost-Effectiveness and Budget Impact of Obesity Surgery in Patients with Type 2 Diabetes in Three European Countries(II). Obes Surg. 2009;19:1542\u20139.","journal-title":"Obes Surg"},{"key":"8639_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.vhri.2019.01.010","volume":"20","author":"Y Gil-Rojas","year":"2019","unstructured":"Gil-Rojas Y, et al. Cost-Effectiveness of Bariatric Surgery Compared With Nonsurgical Treatment in People With Obesity and Comorbidity in Colombia. Value Health Reg Issues. 2019;20:79\u201385.","journal-title":"Value Health Reg Issues"},{"key":"8639_CR23","doi-asserted-by":"publisher","unstructured":"McGlone ER et al. Bariatric Surgery for Patients with Type 2 Diabetes Mellitus Requiring \u0130nsulin: Clinical Outcome and Cost-Effectiveness Analyses. PLoS Med 2020;17:1\u201322.\u00a0https:\/\/doi.org\/10.1371\/journal.pmed.1003228","DOI":"10.1371\/journal.pmed.1003228"},{"key":"8639_CR24","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1007\/s11695-019-03957-7","volume":"29","author":"RP Assump\u00e7\u00e3o","year":"2019","unstructured":"Assump\u00e7\u00e3o RP, et al. Cost-Utility of Gastric Bypass Surgery Compared to Clinical Treatment for Severely Obese With and Without Diabetes in the Perspective of the Brazilian Public Health System. Obes Surg. 2019;29:3202\u201311.","journal-title":"Obes Surg"},{"key":"8639_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.clinthera.2019.12.001","volume":"42","author":"C Rognoni","year":"2020","unstructured":"Rognoni C, Armeni P, Tarricone R, Donin G. Cost\u2013Benefit Analysis in Health Care: The Case of Bariatric Surgery Compared With Diet. Clin Ther. 2020;42:60\u2013e757.","journal-title":"Clin Ther"},{"key":"8639_CR26","doi-asserted-by":"publisher","unstructured":"Viratanapanu I et al. Cost-effectiveness evaluation of bariatric surgery for morbidly obese patients with diabetes in Thailand. J Obes. 2019:5383478:1\u20136.\u00a0https:\/\/doi.org\/10.1155\/2019\/5383478","DOI":"10.1155\/2019\/5383478"},{"key":"8639_CR27","unstructured":"World Bank. 2022. https:\/\/data.worldbank.org\/?locations=XT-TR."},{"key":"8639_CR28","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1002\/bjs.10857","volume":"105","author":"O Borisenko","year":"2018","unstructured":"Borisenko O, Lukyanov V, Ahmed AR. Cost\u2013Utility Analysis of Bariatric Surgery. Br J Surg. 2018;105:1328\u201337.","journal-title":"Br J Surg"},{"key":"8639_CR29","doi-asserted-by":"publisher","unstructured":"Borisenko O, Mann O, Dupr\u00e9e A. Cost-Utility analysis of bariatric surgery compared with conventional medical management in germany: A Decision Analytic Modeling. BMC Surg. 2017;17:1\u20139. https:\/\/doi.org\/10.1186\/s12893-017-0284-0","DOI":"10.1186\/s12893-017-0284-0"},{"key":"8639_CR30","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.2337\/dc10-0554","volume":"33","author":"TJ Hoerger","year":"2010","unstructured":"Hoerger TJ, et al. Cost-Effectiveness of Bariatric Surgery for Severely Obese Adults with Diabetes. Diabetes Care. 2010;33:1933\u20139.","journal-title":"Diabetes Care"},{"key":"8639_CR31","doi-asserted-by":"publisher","unstructured":"Sayg\u0131n Av\u015far T et al. Konsolide Sa\u011fl\u0131k Ekonomisi De\u011ferlendirme Raporlama Standartlar\u0131 T\u00fcrk\u00e7e: Sa\u011fl\u0131k Hizmetlerinin Ekonomik De\u011ferlendirmesinde Raporlama Standartlar\u0131n\u0131n T\u00fcrkiye Uyarlamas\u0131. T\u00fcrkiye Klinikleri Sa\u011fl\u0131k Bilimleri Dergisi. 2023;8(3):1\u201317. https:\/\/doi.org\/10.5336\/healthsci.2023-96248","DOI":"10.5336\/healthsci.2023-96248"},{"key":"8639_CR32","unstructured":"Republic of t\u00fcrkiye social security institution. Health implementation communiqu\u00e9 (SUT). Official Gazette: 24 March 2023; No: 32142."},{"key":"8639_CR33","unstructured":"Ministry of Health (Republic of T\u00fcrkiye). Public Healthcare Service Price Tariff. 2023. Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131. Kamu Sa\u011fl\u0131k Hizmeti Fiyat Tarifesi. https:\/\/shgmsgudb.saglik.gov.tr\/TR-99401\/kamu-saglik-hizmetleri-fiyat-tarifesi-2023-yili.html"},{"key":"8639_CR34","unstructured":"TCMB. TCMB Kurlar Sayfas\u0131. 2023. Central Bank of the Republic of T\u00fcrkiye (CBRT). Exchange Rates. 2023. https:\/\/www.tcmb.gov.tr\/kurlar\/202310\/19102023.xml"},{"key":"8639_CR35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.vhri.2022.09.005","volume":"34","author":"G Redenz","year":"2023","unstructured":"Redenz G, Ibaceta MC, Aceituno D, Balmaceda C, Espinoza MA. Health State Utility Values of Type 2 Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis. Value Health Reg Issues. 2023;34:14\u201322.","journal-title":"Value Health Reg Issues"},{"key":"8639_CR36","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s40273-023-01285-4","volume":"41","author":"M Falk Hvidberg","year":"2023","unstructured":"Falk Hvidberg M, Hern\u00e1ndez Alava M. Catalogues of EQ-5D-3L Health-Related Quality of Life Scores for 199 Chronic Conditions and Health Risks for Use in the UK and the USA. PharmacoEconomics. 2023;41:1287\u2013388.","journal-title":"PharmacoEconomics"},{"key":"8639_CR37","unstructured":"Turkish Statistical Institute. Gross Domestic Product. 2022. (2023). https:\/\/data.tuik.gov.tr\/Bulten\/Index?p=Yillik-Gayrisafi-Yurt-Ici-Hasila-2022-49742"},{"key":"8639_CR38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jval.2016.08.734","volume":"20","author":"MC Gulliford","year":"2017","unstructured":"Gulliford MC, et al. Costs and Outcomes of Increasing Access to Bariatric Surgery: Cohort Study and Cost-Effectiveness Analysis Using Electronic Health Records. Value Health. 2017;20:85\u201392.","journal-title":"Value Health"},{"key":"8639_CR39","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000475842","volume":"10","author":"M Lucchese","year":"2017","unstructured":"Lucchese M, et al. Cost-Utility Analysis of Bariatric Surgery in Italy: Results of Decision-Analytic Modelling. Obes Facts. 2017;10:261\u201372.","journal-title":"Obes Facts"},{"key":"8639_CR40","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/13696998.2017.1419958","volume":"21","author":"O Borisenko","year":"2018","unstructured":"Borisenko O, Lukyanov V, Debergh I, Dillemans B. Cost-Effectiveness Analysis of Bariatric Surgery for Morbid Obesity in Belgium. J Med Econ. 2018;21:365\u201373.","journal-title":"J Med Econ"},{"key":"8639_CR41","unstructured":"Borisenko O, Lukyanov V, Johnsen SP, Funch-Jensen P. Cost analysis of bariatric surgery in Denmark made with a decision-analytic model. Dan Med J. 2017;64(8):A5401. https:\/\/pubmed.ncbi.nlm.nih.gov\/28869031\/"},{"key":"8639_CR42","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1007\/s11695-014-1567-5","volume":"25","author":"O Borisenko","year":"2015","unstructured":"Borisenko O, et al. Bariatric Surgery can Lead to Net Cost Savings to Health Care Systems: Results from a Comprehensive European Decision Analytic Model. Obes Surg. 2015;25:1559\u201368.","journal-title":"Obes Surg"},{"key":"8639_CR43","doi-asserted-by":"publisher","unstructured":"Tang Q et al. Cost-Effectiveness of Bariatric Surgery for Type 2 Diabetes Mellitus: A Randomized Controlled Trial in China. Medicine. 2016;95(20):e3522. https:\/\/doi.org\/10.1097\/MD.0000000000003522","DOI":"10.1097\/MD.0000000000003522"},{"key":"8639_CR44","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/j.soard.2016.12.016","volume":"13","author":"R James","year":"2017","unstructured":"James R, Salton RI, Byrnes JM, Scuffham PA. Cost-Utility Analysis for Bariatric Surgery Compared with Usual Care for the Treatment of Obesity in Australia. Surg Obes Relat Dis. 2017;13:2012\u201320.","journal-title":"Surg Obes Relat Dis"},{"key":"8639_CR45","doi-asserted-by":"publisher","unstructured":"Kov\u00e1cs G, Mohos E, Kis JT, Tab\u00e1k \u00c1, Gerendy P, Pettk\u00f3 J, Nagy D, Gy\u0151rb\u00edr\u00f3 D, Kal\u00f3 Z. Cost-Effectiveness of Bariatric Surgery in Patients Living with Obesity and Type 2 Diabetes. J Diabetes Res. 2023;2023:9686729:1\u20138. https:\/\/doi.org\/10.1155\/2023\/9686729","DOI":"10.1155\/2023\/9686729"},{"key":"8639_CR46","first-page":"167","volume":"6","author":"D\u00d6 Zeybek","year":"2024","unstructured":"Zeybek D\u00d6, Yi\u011fit V. Bariyatrik Cerrahinin Etik Sorunlar\u0131: Sistematik Bir \u0130nceleme. SD\u00dc Sa\u011fl\u0131k Y\u00f6netimi Dergisi. 2024;6:167\u201380.","journal-title":"SD\u00dc Sa\u011fl\u0131k Y\u00f6netimi Dergisi"},{"key":"8639_CR47","doi-asserted-by":"publisher","unstructured":"Lauren BN, et al. Estimated Cost-effectiveness of Medical Therapy, Sleeve Gastrectomy, and Gastric Bypass in Patients with Severe Obesity and Type 2 Diabetes. JAMA Netw Open. 2021;E2148317. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.48317.","DOI":"10.1001\/jamanetworkopen.2021.48317"},{"key":"8639_CR48","first-page":"607","volume":"15","author":"S Ikramuddin","year":"2009","unstructured":"Ikramuddin S, Klingman CD, Swan T, Minshall ME. Cost-Effectiveness of Roux-en-Y Gastric Bypass in Type 2 Diabetes Patients. Am J Managed Care. 2009;15:607\u201315.","journal-title":"Am J Managed Care"},{"key":"8639_CR49","first-page":"123","volume":"1","author":"M Akbolat","year":"2017","unstructured":"Akbolat M, Deniz NG. T\u00fcrkiye\u2019de Medikal Turizmin Geli\u015fimi Ve Baz\u0131 \u00dclkelerle Kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131. Int J Global Tourism Res. 2017;1:123\u201339. https:\/\/dergipark.org.tr\/en\/pub\/ijgtr\/issue\/33240\/366061. Preprint at.","journal-title":"Int J Global Tourism Res"},{"key":"8639_CR50","first-page":"51","volume":"3","author":"B G\u00fcrleyen","year":"2021","unstructured":"G\u00fcrleyen B, \u00c7\u0131nar F. T\u00fcrkiye\u2019nin Medikal Turizm SWOT Analizi: COVID-19 \u00d6rne\u011fi. Sa\u011fl\u0131k ve Sosyal Refah Ara\u015ft\u0131rmalar\u0131 Dergisi. 2021;3:51\u201360.","journal-title":"Sa\u011fl\u0131k ve Sosyal Refah Ara\u015ft\u0131rmalar\u0131 Dergisi"},{"key":"8639_CR51","unstructured":"IQVIA. T\u00fcrkiye Pharmaceutical Sector Report. 2023. https:\/\/www.aifd.org.tr\/wp-content\/uploads\/2023\/12\/IQVIA_TURKIYE-ILAC-SEKTORU_RAPORU_.pdf"},{"key":"8639_CR52","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/14737167.2018.1407649","volume":"18","author":"R Sanchez-Santos","year":"2018","unstructured":"Sanchez-Santos R, et al. Bariatric Surgery Versus Conservative Management for Morbidly Obese Patients in Spain: A Cost-Effectiveness Analysis. Expert Rev Pharmacoecon Outcomes Res. 2018;18:305\u201314.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"8639_CR53","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1007\/s11695-018-3301-1","volume":"28","author":"H Craig","year":"2018","unstructured":"Craig H, le Roux C, Keogh F, Finucane FM. How Ethical Is Our Current Delivery of Care to Patients with Severe and Complicated Obesity? Obes Surg. 2018;28:2078\u201382.","journal-title":"Obes Surg"},{"key":"8639_CR54","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/nrendo.2012.172","volume":"8","author":"J Dixon","year":"2012","unstructured":"Dixon J, Obesity. Health economics of bariatric surgery-benefit versus cost. Nat Rev Endocrinol. 2012;8:632\u20133.","journal-title":"Nat Rev Endocrinol"},{"key":"8639_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/15265161.2010.528509","volume":"10","author":"B Hofmann","year":"2010","unstructured":"Hofmann B. Stuck in the middle: The many moral challenges with bariatric surgery. Am J Bioeth. 2010;10:3\u201311.","journal-title":"Am J Bioeth"},{"key":"8639_CR56","first-page":"268","volume":"90","author":"A Puia","year":"2017","unstructured":"Puia A, Puia IC, Cristea PG. Ethical considerations in bariatric surgery in a developing country. Clujul Med. 2017;90:268\u201372.","journal-title":"Clujul Med"},{"key":"8639_CR57","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s11695-011-0386-1","volume":"21","author":"SI Saarni","year":"2011","unstructured":"Saarni SI, et al. Ethical issues of obesity surgery\u2013a health technology assessment. Obes Surg. 2011;21:1469\u201376.","journal-title":"Obes Surg"},{"issue":"7","key":"8639_CR58","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/MLR.0000000000000154","volume":"52","author":"Z Yang","year":"2014","unstructured":"Yang Z, Zhang N. The Burden of Overweight and Obesity on Long-Term Care and Medicaid Financing. Med Care. 2014;52(7):658\u201363.","journal-title":"Med Care"},{"key":"8639_CR59","doi-asserted-by":"publisher","unstructured":"Wang YC, Pamplin J, Long MW, Ward ZJ, Gortmaker SL, Andreyeva T. Severe Obesity in Adults Cost State Medicaid Programs Nearly $8 Billion n 2013. Health Aff. 2015;34(11):1923\u201331.\u00a0https:\/\/doi.org\/10.1377\/hlthaff.2015.0633","DOI":"10.1377\/hlthaff.2015.0633"},{"key":"8639_CR60","doi-asserted-by":"publisher","first-page":"6351","DOI":"10.1136\/bmjgh-2021-006351","volume":"6","author":"A Okunogbe","year":"2021","unstructured":"Okunogbe A, Nugent R, Spencer G, Ralston J, Wilding J. Economic Impacts of Overweight and Obesity: Current and Future Estimates for Eight Countries. BMJ Global Health. 2021;6:6351.","journal-title":"BMJ Global Health"},{"issue":"9","key":"8639_CR61","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s10198-015-0751-4","volume":"17","author":"T Effertz","year":"2016","unstructured":"Effertz T, Engel S, Verheyen F, Linder R. The Costs and Consequences of Obesity in Germany: A New Approach From a Prevalence and Life-Cycle Perspective. Eur J Health Economics: HEPAC : Health Econ Prev Care. 2016;17(9):1141\u201358.","journal-title":"Eur J Health Economics: HEPAC : Health Econ Prev Care"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08639-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-026-08639-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08639-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T17:58:30Z","timestamp":1780163910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-026-08639-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["8639"],"URL":"https:\/\/doi.org\/10.1007\/s11695-026-08639-9","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the study was obtained from the S\u00fcleyman Demirel University Social and Human Sciences Ethics Committee\u00a0before accessing patient data (Approval No: 5, Date: 25 November 2020, Decision No: 46). Administrative permissions to access\u00a0patient data for the years 2020\u20132021 were obtained from the Chief Physician Offices of Bal\u0131kesir Health Practice and Research\u00a0Hospital and S\u00fcleyman Demirel University Research and Practice Hospital. The study was conducted in accordance with the\u00a0principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}